| 生物活性 | |||
|---|---|---|---|
| 靶点 |
|
||
| 描述 | ASP3026 is a potent, selective, and orally administered inhibitor of anaplastic lymphoma kinase (ALK). It promotes apoptosis in tumor cells and is applicable in non-small cell lung cancer (NSCLC) research[1][2]. | ||
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
|
1 mM 5 mM 10 mM |
1.72mL 0.34mL 0.17mL |
8.61mL 1.72mL 0.86mL |
17.22mL 3.44mL 1.72mL |
| 参考文献 |
|---|